Juno Bio is a women's health company focused on precision vaginal microbiome testing and multi-omics. Recently, the business opened its first CLIA-certified sequencing laboratory in Oakland, California. Dedicated entirely to women's health, this move represents a significant expansion of its clinical infrastructure to scale provider-led care and advance precision diagnostics.
Juno Bio has raised $3.8 million from investors including Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator to support this growth. The brand's precision vaginal microbiome testing and multi-omics platform utilizes next-generation sequencing to analyze approximately 10,000 bacteria and fungi alongside four common sexually transmitted infections.
The new clinically actionable test, which builds on the company's original wellness test that sold over 20,000 units organically, is designed to address recurrent infections, fertility concerns, and peri- and menopausal symptoms that are frequently misunderstood or inadequately treated in conventional healthcare settings.
Certified Sequencing Laboratories
Juno Bio's Vaginal Microbiome Testing is Trustworthy
Trend Themes
-
Certified Microbiome Diagnostics — CLIA-certified sequencing labs dedicated to niche microbiome categories create new pathways for trusted, clinically actionable testing beyond traditional broad-spectrum diagnostics.
-
Women-centered Precision Care — Precision platforms focused on vaginal health signal growing demand for specialized data models that address recurrent infections, fertility, and menopause-related symptoms.
-
Multi-omics Consumer-to-clinic Platforms — Wellness tests evolving into provider-led clinical tools reveal opportunities for brands to bridge direct-to-consumer adoption with regulated healthcare delivery.
Industry Implications
-
Women’s Health — Specialized diagnostics for underserved symptoms expand the category from reproductive care into longitudinal, personalized health management.
-
Biotechnology — Next-generation sequencing applied to microbiome analysis supports differentiated clinical products built around high-resolution microbial and fungal profiling.
-
Clinical Laboratory Services — Dedicated certified labs for emerging diagnostic segments introduce scalable infrastructure for faster validation, care integration, and provider trust.